Key enzymes involved in the synthesis (isocitrate dehydrogenase (IDH) and CS), transport (NaCT and CTP), or breakdown (ACLY and IDH) of citrate are potential therapeutic targets as they influence disease pathogenesis, including brain disorders and cancer. Here, IDH1 is linked to brain disorder.